Bladder Cancer Academy

Registration now open

February 28 – March 1, 2019

Marriott st. louis airport

st. louis, missouri

Advantages for LUGPA Members:
  • The latest, most relevant information on bladder cancer treatment and management, delivered by experts in the field. It’s an easy way to stay up-to-speed with information that is critical to your patient’s care.
  • An interactive meeting format, including didactic lectures, case-based discussions, and faculty panels. Fast moving, but highly informative, it’s sure to keep you engaged.
  • Outstanding networking with urology residents, who are eager to meet independent practice physicians.
  • BCA attendees receive travel reimbursement, including round-trip airfare, two (2) nights lodging and on-site meals for the duration of the program.

In our shared goal to ensure that our members receive optimal education on advances in bladder cancer treatment and to optimize patient management, LUGPA is pleased to co-sponsor the 2019 Bladder Cancer Academy program with MedReviews, LLC, publishers of Reviews in Urology,® LUGPA’s official journal.

Program Co-Chairs:
Arjun V. Balar, MD
Assistant Professor, Department of Medicine
Director, Genitourinary Medical Oncology Program
NYU Langone Medical Center
New York, NY
Herbert Lepor, MD
Professor, Department of Urology
Martin Spatz Chair, Department of Urology
Professor, Department of Biochemistry and
Molecular Pharmacology
NYU Langone Medical Center
New York, NY
Neal D. Shore, MD, FACS
President, LUGPA
Medical Director, Certified Physician Investigator
Carolina Urologic Research Center
Atlantic Urology Clinics
Myrtle Beach, SC

2018 Bladder Cancer Academy Agenda

Thursday, March 1, 2018

6:30 p.m. – 8:30 p.m. Registration Desk Open
6:30 p.m. – 8:30 p.m. Welcome Dinner

Friday, March 2, 2018

7:50 a.m. Welcome and Introductions
8:00 a.m. – 8:50 a.m. Breakfast
8:55 a.m. Why LUGPA Embraces Managing Advanced Genitourinary Cancers Neal D. Shore, MD
Carolina Urologic Research Center
Atlantic Urology Clinics
9:35 a.m. Bladder Cancer Biomarkers: New and Old Michael Cookson, MD, MMHC
The University of Oklahoma Health Sciences Center
10:15 a.m. Quality Indicators and Enhanced Imaging in Cystoscope and TURBT Michael Cookson, MD, MMHC
The University of Oklahoma Health Sciences Center
10:55 a.m. – 11:20 a.m. Morning Break
11:25 a.m. Intravesical Therapy for High-risk Disease Colin P. Dinney, MD
The University of Texas
MD Anderson Cancer Center
12:05 p.m. Intravesical Therapy: When Bacillus Calmette-Guerin Fails Noah M. Hahn, MD
Johns Hopkins University School of Medicine
12:45 p.m. Case Presentation with Panel Discussion
1:15 p.m. – 2:15 p.m. Lunch
2:20 p.m. Bladder-sparing Strategies Jason A. Efstathiou, MD, DPhil
Harvard Medical School
Massachusetts General Hospital
3:00 p.m. Neoadjuvant and Adjuvant Chemotherapy: Bladder Cancer Matthew Galsky, MD
Mount Sinai School of Medicine
3:40 p.m. – 4:05 p.m. Afternoon Break
4:10 p.m. Immunotherapy of Advanced Bladder Cancer: The Next Frontier Jonathan E. Rosenberg, MD
Memorial Sloan Kettering Cancer Center
4:50 p.m. Case Presentation with Panel Discussion
5:20 p.m. Wrap-up Session
5:30 p.m. – 6:30 p.m. Networking Reception
6:30 p.m. – 7:30 p.m. Dinner

Saturday, March 3, 2018

7:00 a.m. Welcome Remarks
7:10 a.m. – 8:00 a.m. Breakfast
8:05 a.m. Managing Small Renal Masses Robert G. Uzzo, MD, FACS
Fox Chase Cancer Center
8:45 a.m. Surgical Management of Renal Cell Carcinoma Robert G. Uzzo, MD, FACS
Fox Chase Cancer Center
9:25 a.m. Systemic Renal Therapies: Targeted Molecules Anil Kapoor, MD
McMaster University
St. Joseph’s Hospital Hamilton
10:05 am – 10:30 am Morning Break
10:35 a.m. Systemic Therapies for Renal Cell Carcinoma: Combinations Beyond Single Agent PD-1 Hans Hammers, MD, PhD
UT Southwestern – Kidney Cancer Program
11:15 a.m. The Future of Genitourinary Cancers and Beyond Arjun V. Balar, MD
NYU Langone Medical Center
11:55 a.m. Closing Remarks
12:00 p.m. Departures